Intracellular Price Fair Value from 2010 to 2025

ITCI Stock  USD 128.25  0.21  0.16%   
Intracellular's Price Fair Value is decreasing with slightly volatile movements from year to year. Price Fair Value is estimated to finish at 7.71 this year. For the period between 2010 and 2025, Intracellular, Price Fair Value quarterly trend regression had mean deviation of  4.81 and range of 18.0993. View All Fundamentals
 
Price Fair Value  
First Reported
2010-12-31
Previous Quarter
7.50004575
Current Value
7.71
Quarterly Volatility
6.25014816
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Intracellular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intracellular's main balance sheet or income statement drivers, such as Interest Expense of 8.9 M, Total Revenue of 714.9 M or Gross Profit of 655.1 M, as well as many indicators such as Price To Sales Ratio of 12.02, Dividend Yield of 0.0 or PTB Ratio of 7.71. Intracellular financial statements analysis is a perfect complement when working with Intracellular Valuation or Volatility modules.
  
Check out the analysis of Intracellular Correlation against competitors.

Latest Intracellular's Price Fair Value Growth Pattern

Below is the plot of the Price Fair Value of Intracellular Th over the last few years. It is Intracellular's Price Fair Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intracellular's overall financial position and show how it may be relating to other accounts over time.
Price Fair Value10 Years Trend
Slightly volatile
   Price Fair Value   
9.713.4110.17.5911.67.507.71-65%199%-25%53%-35%3%100%
       Timeline  

Intracellular Price Fair Value Regression Statistics

Arithmetic Mean8.63
Geometric Mean6.45
Coefficient Of Variation72.46
Mean Deviation4.81
Median7.71
Standard Deviation6.25
Sample Variance39.06
Range18.0993
R-Value(0.41)
Mean Square Error34.87
R-Squared0.17
Significance0.12
Slope(0.54)
Total Sum of Squares585.97

Intracellular Price Fair Value History

2025 7.71
2024 7.5
2023 11.61
2022 7.59
2021 10.18
2020 3.41
2019 9.71

About Intracellular Financial Statements

Investors use fundamental indicators, such as Intracellular's Price Fair Value, to determine how well the company is positioned to perform in the future. Although Intracellular's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Price Fair Value 7.50  7.71 

Currently Active Assets on Macroaxis

When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:
Check out the analysis of Intracellular Correlation against competitors.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Intracellular. If investors know Intracellular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Intracellular listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.72)
Revenue Per Share
6.602
Quarterly Revenue Growth
0.508
Return On Assets
(0.07)
Return On Equity
(0.09)
The market value of Intracellular Th is measured differently than its book value, which is the value of Intracellular that is recorded on the company's balance sheet. Investors also form their own opinion of Intracellular's value that differs from its market value or its book value, called intrinsic value, which is Intracellular's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Intracellular's market value can be influenced by many factors that don't directly affect Intracellular's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Intracellular's value and its price as these two are different measures arrived at by different means. Investors typically determine if Intracellular is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Intracellular's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Trending Assets

DCPH
Deciphera Pharmaceuticals
0.00  0.00  0.00 
EGRX
Eagle Pharmaceuticals
0.00  0.00  0.00 
PCRX
Pacira BioSciences,
25.38  -0.1  -0.39 
ALKS
Alkermes Plc
34.04  -0.76  -2.18 
News Freq…Investor S…100%